InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Thompson Tommy G, Director. Insider active across 6 companies, notably TherapeuticsMD, Inc.. Aggregated, 48 reports have been published. Split: 7 buys · 1 sell. Total volume traded: €457k. Activity tracked since 14 May 2021. The latest transaction was filed on 26 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Thompson Tommy G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations48 total
2,000 shares@ US$101.803.5% of flowCommon StockSEC:0001324863-26-000002:0
2,000 shares@ US$101.802.9% of flowCommon StockSEC:0001324863-26-000001:0
8,400 shares@ US$1.670348.2% of flowCommon StockSEC:0000905148-25-004488:0
Canonical exit: 23 Mar 2026 (T+90)
910 shares@ US$101.801.3% of flowCommon StockSEC:0001324863-25-000004:0
4,560 shares@ US$229.8115.2% of flowCommon StockSEC:0001324863-25-000003:0
5,777 shares@ US$17.2750.2% of flowCommon StockSEC:0001628280-25-028115:0
Canonical exit: 26 Aug 2025 (T+90)
2,500 shares@ US$175.438.1% of flowCommon StockSEC:0001562180-25-003762:0
5,700 shares@ US$17.3638100.0% of flowCommon StockSEC:0001628280-25-024517:0
Canonical exit: 7 Aug 2025 (T+90)
10,657 shares0Common StockSEC:0001628280-25-020763:0
325 shares@ US$1.00181.1% of flowCommon StockSEC:0000905148-25-001216:0
Canonical exit: 13 Jul 2025 (T+90)
2,500 shares@ US$175.438.4% of flowCommon StockSEC:0001562180-25-002735:0
2,500 shares@ US$175.438.7% of flowCommon StockSEC:0001562180-25-001841:0
8,500 shares0Common StockSEC:0000905148-25-000738:0
7,500 shares@ US$175.4325.5% of flowCommon StockSEC:0001415889-24-018435:0
9,575 shares0Common StockSEC:0001628280-24-019414:0
5,000 shares@ US$88.038.3% of flowCommon StockSEC:0001415889-24-007632:0
2,000 shares@ US$88.033.3% of flowCommon StockSEC:0001415889-24-007511:0
2,000 shares@ US$88.033.4% of flowCommon StockSEC:0001415889-24-007186:0
2,000 shares@ US$88.033.4% of flowCommon StockSEC:0001415889-24-006292:0
4,582 sharesCommon shares, $0.01 par valueSEC:0001574540-24-000067:0
2,000 shares@ US$88.033.4% of flowCommon StockSEC:0001415889-24-005242:0
880 shares0Common StockSEC:0001415889-23-010953:0
1,000 shares@ US$88.031.7% of flowCommon StockSEC:0001415889-23-009795:0
1,000 shares@ US$88.031.7% of flowCommon StockSEC:0001415889-23-009238:0
2,500 shares@ US$63.903.1% of flowCommon StockSEC:0001415889-23-005793:0
25 of 48 declarations
About Thompson Tommy G
Thompson Tommy G is Administrateur and has 48 filings in total. In the 48 sampled recent filings, buys amount to EUR 457150, sells to EUR 0, the most frequent transaction nature is Levée d'options, and the period runs from 2016-01-05 to 2026-03-26. The recent filings involve UNITED THERAPEUTICS Corp, TherapeuticsMD, Inc., HEALTHPEAK PROPERTIES, INC., Physicians Realty Trust, CENTENE CORP and BARD C R INC /NJ/, with several notable filings at UNITED THERAPEUTICS Corp, including amounts of EUR 1231939.643748692 on 2024-06-28, EUR 895406.8473507402 on 2025-09-10, and EUR 421904.7826866269 on 2025-03-03.
